Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees. The firm manufacture and distribute its products through facilities in the United States, including Puerto Rico, and in Europe and Asia. The Company’s products are sold in approximately 90 countries. Its Cardiometabolic Health products Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound, and others. Its oncology products include Cyramza, Erbitux, Tyvyt, Verzenio, Retevmo, Jaypirca, and others. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. Its LillyDirect, a direct-to-patient digital health care platform, provides delivery of select Lilly medicines dispensed by third-party pharmacies to patients.
Mr. David Ricks 2012 'den beri şirketle birlikte olan Eli Lilly and Co 'in Chairman of the Board 'ıdır.
LLY hissesinin fiyat performansı nasıl?
LLY 'in mevcut fiyatı $965.95 'dir, son işlem günde 0.11% azalmış etti.
Eli Lilly and Co için ana iş temaları veya sektörler nelerdir?
Eli Lilly and Co Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Eli Lilly and Co 'in piyasa değerlemesi nedir?
Eli Lilly and Co 'in mevcut piyasa değerlemesi $912.6B 'dir
Eli Lilly and Co al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 34 analist Eli Lilly and Co için analist derecelendirmeleri gerçekleştirdi, bunlar 9 güçlü al, 17 al, 9 tut, 0 sat ve 9 güçlü sat içermektedir